Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05612490

Furosemide Stress Test to Predict Successful Liberation From RRT

Conditions: Acute Kidney Injury

Sex: All
Ages: 18 Years – N/A
Enrollment: 60
Sponsor: Centre Hospitalier Universitaire Vaudois

Location: Switzerland

Summary

The proposed study will evaluate if a standardised dose of furosemide administered in the 12 hours after RRT liberation can predict successful liberation in critically ill patients. The dose that will be administered is in accordance with the prescribing information.

Eligibility Criteria

Inclusion Criteria:Receiving continuous RRT for AKIHaving an indwelling urinary catheterClinical decision by physician in charge to attempt RRT liberation (first attempt)lnformed consent signed by the patient himself / legal representative or authorization received from independent physicianExclusion Criteria:Electrolyte disturbances or hemodynamic instability precluding the use of furosemide (sodium > 155 mmol/L and/or potassium < 3.0 mmol/L and/or metabolic alkalosis > 7.50 and/or mean arterial pressure < 60 mmHg)Furosemide allergyUrine output ≥ 100 mL/h for at least two hoursPrior FST during the ICU stayKnown end-stage chronic renal disease at ICU admissionWithdrawal of life support decision taken before inclusionPatient already participating in conflicting research study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05612490). StuddyBuddy aggregates publicly available trial information.